UPDATE: Korro Bio and Frequency Therapeutics Announce Closing of Merger and Private Placement of $117 Million

Korro will be focused on advancing a wholly owned portfolio of RNA editing programsPost-transaction cash of approximately $170 million expected to...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Israel ,Massachusetts ,United States ,Israeli ,Piper Sandler ,Nessan Bermingham ,Tim Pearson ,Ali Behbahani ,Ram Aiyar ,Korro Bio ,Davidl Lucchino ,Goodwin Procter ,Verition Fund Management ,Latham Watkins ,Korro Bio Inc ,Frequency Therapeutics Inc ,Atlas Venture ,Nasdaq ,Davis Polk Wardwell ,Jp Morgan Securities ,Frequency Therapeutics ,Nasdaq Capital Market ,Surveyor Capital ,Cormorant Asset Management ,Eventide Asset Management ,Qiming Venture Partners United States ,Venture Management ,Monashee Investment Management ,Sixty Degree Capital ,Chief Executive Officer ,Davis Polk ,Securities Litigation Reform Act ,